High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype

<div>Survival curves of CRC patients by the Kaplan-Meier method and the log-rank test. (a) Patients with high LTBP2 expression (blue line) had significantly worse overall survival than those with low LTBP2 expression (red line). (b) In TCGA database, the high expression of LTBP2 (blue line) predicts poor overall survival for CRC patients.</div>

Disease Markers

fig3

Figure 3

Figure 3: High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype 

Figure 3 | High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype 